Verici is a biotechnology company focused on developing innovative solutions for organ transplant patients. Their primary goal is to improve patient outcomes by providing advanced diagnostic tools that help assess the risk of organ rejection. The company's flagship product is a blood test that analyzes specific biomarkers, allowing healthcare providers to monitor transplant patients more effectively. By offering personalized insights, Verici aims to enhance the management of transplant care and ultimately improve the quality of life for patients who have undergone procedures such as kidney or liver transplants.